课题基金 / 基金详情

项目摘要

项目成果

GARNETT H KELSOE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have added Core E, to support a new joint Aim of the POI, described in both in the plans for the coming year in Project 3 and more briefly in Project 1. Dr. Kelsoe, the Pi of this Core, has been working closely with Haynes, Liao, and Harrison, and he is a coauthor (with Haynes, Harrison, and Kepler) ofthe review that describes (and names) B-cell lineage based immunogen design (Haynes, B.F., Kelsoe, G., Harrison, S.C, Kepler, T.B. B-cell-lineage immunogen design in vaccine development with HlV-1 as a case study. Nature Biotechnology 10: 423 (2012), PMC3512202). The novel, single-cell, B-cell culture system will allow us to test this notion on a feasible timescale in a tractable mouse model, and it will yield data that should facilitate more realistic models of the germinal center reaction and antibody affinity maturation (in humans as well as in mice) in the context of an influenza virus immunogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nab evolution in humans and RMs
  • 批准号:
    10117177
  • 项目类别:
  • 资助金额:
    $68.99万
  • 财政年份:
    2017
  • 负责人:
    GARNETT H KELSOE
  • 依托单位:
Immunity to novel T/F SHIVs: variability in the co-evolution of virus and host immunity
  • 批准号:
    10200002
  • 项目类别:
  • 资助金额:
    $77.7万
  • 财政年份:
    2017
  • 负责人:
    GARNETT H KELSOE
  • 依托单位:
Optimizing Humoral Responses to HIV-1 Env Vaccine Antigens
  • 批准号:
    10631900
  • 项目类别:
  • 资助金额:
    $88.55万
  • 财政年份:
    2017
  • 负责人:
    GARNETT H KELSOE
  • 依托单位:
Optimizing Humoral Responses to HIV-1 Env Vaccine Antigens
  • 批准号:
    10370984
  • 项目类别:
  • 资助金额:
    $90.11万
  • 财政年份:
    2017
  • 负责人:
    GARNETT H KELSOE
  • 依托单位:
海外基金